Close this search box.

TROG 13.01 – SAFRON II Dataset

Dataset Name:

TROG 13.01 SAFRON II Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial




TROG Cancer Research


A/Prof Shankar Siva


Australian Lung Cancer Trials Group (ALTG)

Date made available:



Individual Participant Data

Subject (ANZSRC Category):

Radiation therapy

Patient sample size:


Dataset Description:

Dataset Contains:
– Toxicity grade 3 or higher related to SABR treatment
– Quality of life (EQ-5D and MDASI-LC)
– Time to local failure
– Overall survival
– Time to distant failure
– Disease free survival
– Resources use and costs associated with treatment (MBS/PBS data. Hospitalisations. QALYs)
– Imaging data (CT)
– Approx time period of data collection 2015-2021

Radiotherapy Quality Assurance
– 89 RTQA imaging datasets
– 22 benchmarking datasets
– RT plans, RT delivery and imaging documentation, LRF (DICOM format)


Cancer Australia, Auckland Medical Research Foundation

Keywords (MeSH):

Dose Fractionation, Radiation*; Health Care Costs; Health Resources; Humans; Lung Neoplasms/diagnosis; Lung Neoplasms/secondary*; Lung Neoplasms/therapy*; Quality of Life; Radiosurgery*/economics; Radiosurgery*/methods; Radiotherapy/economics; Radiotherapy/methods*; Tomography, X-Ray Computed; Tumor Burden

ANZCTR Reference:



A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

Requests for Data:

Access can be requested via the Health Data Australia catalogue. Search for the ACTRN number in the catalogue to find datasets associated with this trial or email enquiries to

Please submit a New Trial Proposal Application (Category D) to the TROG Cancer Research Operations Executive Committee.